As of Apr 24
| -0.51 / -0.47%|
The 13 analysts offering 12-month price forecasts for Incyte Corp have a median target of 92.00, with a high estimate of 105.00 and a low estimate of 80.00. The median estimate represents a -14.29% decrease from the last price of 107.34.
The current consensus among 15 polled investment analysts is to Buy stock in Incyte Corp. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.